Hind Benjelloun
Psychiatry · Washington, DCNPI 1053577437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $741 and has fallen 94.8% since, to $38 in 2025. Among psychiatry clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$495
- Ironshore Pharmaceuticals Inc.$265
- AbbVie$226
- Corium, LLC$204
- Tris Pharma Inc$143
- Otsuka America Pharmaceutical, Inc.$125
- plus $633 from 10 others
What the payments were for
- Food & beverage$2,081100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 24 | $495 |
| Ironshore Pharmaceuticals Inc. | 16 | $265 |
| AbbVie | 14 | $226 |
| Corium, LLC | 10 | $204 |
| Tris Pharma Inc | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 7 | $125 |
| Neos Therapeutics, LP | 6 | $119 |
| Axsome Therapeutics, Inc. | 5 | $91 |
| Johnson & Johnson | 4 | $85 |
| Lundbeck LLC | 4 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Bausch Health US, LLC | 3 | $48 |
| Avanir Pharmaceuticals, Inc. | 3 | $48 |
| Alkermes, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$107
How this compares
$2,089 in reported general payments places this provider in the 90th percentile of 226 psychiatry providers in District of Columbia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 13 | $29,582 |
| Guanfacine Hcl ErGuanfacine Hcl | 13 | $489 |
| Sertraline Hcl | 31 | $414 |
| Quetiapine Fumarate | 23 | $348 |
| Bupropion XlBupropion Hcl | 21 | $319 |
| Duloxetine Hcl | 14 | $295 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $201 |
| Escitalopram Oxalate | 16 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $85 | $29,58213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 226 psychiatry providers in District of Columbia.
Other psychiatry in Washington
- Ikechi NnawuchiWashington$624K
- James GordonWashington$20K
- Thomas MellmanWashington$19K
- Tony GoreWashington$11K
- Dwight KingWashington$10K
- Igor VolkovWashington$10K
- Joel KleinmanWashington$8K
- Vivienne GomesWashington$6K
- Irfan SaeedWashington$6K
- Arda KasaciWashington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.